Neuropeptide FF-like immunoreactivity in human cerebrospinal fluid of chronic pain patients and healthy controls

Peptides

Volumn 18, Issue 7, 1997, Pages 923-927

  Sunblom, D M ^a,c   Kalso, E ^a   Tigerstedt, I ^a   Walbeck, K ^a   Panula, P ^b   Fryrquist, F ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

Cerebrospinal fluid; Human; Neuropeptide FF; Pain; Plasma

Indexed keywords

NEUROPEPTIDE FF;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; AGED; BRAIN; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; NEUROPEPTIDES; OLIGOPEPTIDES; PAIN;

MAMMALIA;

EID: 0030698087     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00040-5     Document Type: Article

References (54)

1. Aarnisalo A. A., Panula P. Neuropeptide FF-containing efferent projections from the medial hypothalamus of rat A Phaseolus vulgaris leucoagglutinin study. Neuroscience. 65:1995;175-192.
2. Allard M., Jordan D., Zajaz J. M., Ries C., Martin D., Moukouanga D., Kopp N., Simonet G. Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res. 633:1994;127-132.
3. Allard M., Labrouche S., Nosejean A., Laguzzi R. Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat. J. Pharamcol. Exp. Ther. 274:1995;577-583.
4. Allard M., Theodosis D. T., Rousselet P., Lombard M., Simonnet G. Characterization and localization of a putative morphine-modulating peptide, FLFQPQRF-amide, in the spinal cord Biochemical and immunocytochemical studies. Neuroscience. 40:1991;81-92.
5. Almay, B. G. Patinets with idiopathic pain syndroms. A clinical, biochemical and neuroendocrinological study. Umeå: Umeå University, Vol. Umeî University Med Diss No 191.; 1987:
6. Almay B. G. L., Johansson F., Knorring L. v., Terenius L., Wahlström A. Endorphins in chronic pain Differences in CSF endorphin levels between organic and psychogenic pain syndroms. Pain. 5:1978;153-162.
7. American Psychiatric Association diagnostic and statistical manual of mental disorders. 1994;American Psychiatric Association, Washington DC.
8. Bach F. W., Langemark M., Secher N. H., Olesen J. Plasma and cerebrospinal fluid beta-endorphin in chronic tension-type headache. Pain. 51:1992;163-168.
9. Bach F. W., Schmidt J. F., Faber T. Radioimmunoassay of beta-endorphin in human ventricular and lumbar cerebrospinal fluid. Clin. Chem. 38:1992;847-852.
10. Bonica J. J. The management of pain. 1990;181 Lea and Febiger, Philadelphia & London.
11. 2-like peptide, blocks opiate effects on ileum contractions. Peptides. 14:1993;1005-1009.
12. Facchinetti F., Nappi G., Savoldi F., Genazzani A. R. Primary headaches Reduced circulating beta-lipotropin and beta-endorphin levels with impaired reactivity to acupuncture. Cephlagia. 1:1981;195-201.
13. Fehmann H. C., NcGregor G., Weber V., Eissele R., Göke R., Göke B., Arnold R. The effect of two FMRFamide related peptides (A-18-F-amide and F-8-F-amide; "morphine modulating peptides") on the endocrine and exocrine rat pancreas. Neuropeptides. 17:1990;87-92.
14. Fettes I., Gawal M., Kuzniak S., Edmeads J. Endorphin levels in headache syndroms. Headache. 25:1985;37-39.
15. Genazzani A. R., Nappi G., Facchinetti F., Micieli G., Peteraglia F., Bono G., Monittola C., Savoldi F. Progressive impairment of CSF beta-EP levels in migraine sufferers. Pain. 18:1984;127-133.
16. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J. M. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur. J. Pharmacol. 222:1992;61-67.
17. Gjerris A., Gjerris F., Sørensen P. S., Sørensen N. J., Fahrenkrug J., Rehfeld J. F. Do concentrations of neurotransmitters measured in lumbar cerebrospinal fluid reflect the concentrations at brain levels. Acta Neurochr. (Wien). 91:1988;55-59.
18. Gouarderes C., Sutak M., Zajac J. M., Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237:1993;73-81.
19. Guilford J. P. Psychometric methods. 1954;McGraw Hill, New York.
20. Hasumi K., Kobayashi S., Hazato T., Hase K., Kaya K. A study of the leucine enkephalin like substance and enkephalin degrading enzyme activity in human cerebrospinal fluid (Japanese). Masui. 38:1989;1177-1180.
21. Jolkkonen J., Hartikainen P., Soikkeli R., Bissette G., Nemeroff C., Riekkinen P. A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease. Neuropeptides. 19:1991;97-102.
22. Kavaliers M. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide) related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci. Lett. 115:1990;307-312.
23. Kavaliers M., Coldwell D. C. Neuropeptide-FF (FLFQPQRFamide) and IgG from neuropeptide FF antiserum affect spatial learning in mice. Neurosci. Lett. 157:1993;75-78.
24. Kavaliers M., Innes D. Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia. Peptides. 13:1992;603-607.
25. 2-related peptides augments morphine- and stress-induced analgesia in mice. Peptides. 10:1989;741-745.
26. 2-related peptides and IgG from antiserum against them on aggression and defeat-induced analgesia in mice. Peptides. 12:1991;235-239.
27. Kivipelto L. Ultrastroctural localization of neuropeptide FF in the brain and pituitary of rats. Regul. Pept. 34:1991;211-224.
28. Kivipelto L., Majane E. A., Yang H.-Y.T., Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamide-like peptides in the central nervous system of rats. J. Comp. Neurol. 286:1989;269-287.
29. Kupers R. C., Konings H., Adriaensen H., Gybels J. M. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain. 47:1991;5-12.
30. Lake J. R., Hammond M. V., Shaddox R. C., Hunsicker L. M., Yang H.-Y.T., Malin D. H. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci. Lett. 132:1991;29-32.
31. Langemark M., Bach F. W., Ekman R., Olesen J. Increased cerebrospinal fluid Met-enkephalin immunoreactivity in patients with chronic tension-type headache. Pain. 63:1995;103-107.
32. Lee C.-H., Wasowicz K., Majane E. A., Yang H.-Y. T., Panula P. Distribution and characterisation of Neuropeptide FF-like immunoreactivity in the rat nervous system with a monoclonal antibody. Eur. J. Neurosci. 5:1993;1339-1348.
33. 2-like peptide. Brain Res. 494:1989;1-12.
34. 2-like peptide in rat pituitary Decrease by osmotic stimulus . Peptides. 12:1991;1303-1308.
35. Majane E. A., Zhu J., Aarnisalo A. A., Panula P., Yang H.-Y.T. Origin of neurohypophyseal neuropeptide-FF (FLFQPQRF-NH2). Endocrinol. 133:1993;1578-1584.
36. 2-like mammalian octapeptide Possible role in opiate dependence an abstinence. Peptides. 11:1990;969-972.
37. Matucci-Cerinic M., Lombardi A., Leoncini G., Pignone A., Sacerdoti L., Spillantini M. G., Partsch G. Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis A marker of disease activity or a regulator of pain and inflammation? Rheumatol. Int. 13:1993;1-4.
38. Oberling P., Stinus L., Le Moal M., Simonnet G. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides. 14:1993;919-924.
39. Panula P., Aarnisalo A. A., Wasowicz K. Neuropeptide FF; a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48:1996;461-467.
40. 2), inhibits colonic bead expulsion time in mice. Peptides. 10:1989;873-875.
41. Raffa R. B., Kim A., Rice R. C., deCosta B. R., Codd E. E., Rothman R. B. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors. Peptides. 15:1994;401-404.
42. 2 antiserum. Neuropeptides. 10:1987;37-42.
43. 2 (NPFF), downregulates mu opioid binding sites in the rat brain. Peptides. 14:1993;1271-1277.
44. Rothman R. B., Yang H.-Y.T., Long J. B. Upregulation of rat brain opioid receptors by the chronic administration of morphine: Possible evidence for an anti-opiate model of tolerance and dependence. NIDA Res. Monogr. 105:1991;264-270.
45. 2 sera detects pancreatic polypeptide cells in the rat islet. Peptides. 5:1984;777-782.
46. Spitzer, R. L.; Williams, J. B. W.; Gibbon, M.; First, M. B. Structured Clinical Interview for DSM-III-R- Patient Version (SCID-P 4/1/88). New York: Biometric Research Department, New York State Psychiatric Institute; 1988.
47. Sundblom D. M., Haikonen S., Niemi-Pynttäri J., Tigerstedt I.-W. Effect of spiritual healing on chronic idiopathic pain A medical and psychological study. Clin. J. Pain. 10:1994;296-302.
48. Sundblom D. M., Panula P., Fyhrquist F. Neuropeptide FF-like immunoreactivity in human plasma. Peptides. 16:1995;347-350.
49. Tsubokawa T., Yamamoto T., Katayama Y., Hirayama T., Sibaya H. Thalamic relay nucleus stimulation for relief of intractable pain Clinical results and beta-endorphin immunoreactivity in the cerebrospinal fluid. Pain. 18:1984;115-126.
50. Vaerøy H.; Helle, R.; Førre Ø., Kåss E.;, Terenius L. Cerebrospinal fluid levels of beta-endorphin in patientswith fibromyalgia. (fibrositis syndrome). J. Rheumatol. 15:1988;1804-1806.
51. Vaerøy H., Nyberg F., Terenius L. No evidence for endorphin deficiency in fibromyalgia following invetsigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg-Phe. Pain. 46:1991;139-143.
52. Vilim E. S., Ziff E. Cloning of the neuropeptide NPFF and NPAF precursor from bovine, rat, mouse and human. Soc. Neurosci. Abstr. 21:(1):1995;760.
53. Wiertelak E. P., Yang H. Y., Mooney-Heiberger K., Maier S. F., Watkins L. R. The nature of conditioned anti-analgesia Spinal cord opiate and anti-opiate neurochemistry. Brain Res. 634:1994;214-226.
54. Yang H.-Y.T., Fratta W., Majane E. A., Costa E. Isolation, sequencing synthesis, and pharamacological characterization of two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. USA. 82:1985;7757-7761.